β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis

被引:0
|
作者
Uta Drebber
Martin Madeja
Margarete Odenthal
Inga Wedemeyer
Stefan P. Mönig
Jan Brabender
Elfriede Bollschweiler
Arnulf H. Hölscher
Paul M. Schneider
Hans P. Dienes
Daniel Vallböhmer
机构
[1] University Hospital Cologne,Institute of Pathology
[2] University Hospital Cologne,Department of General, Visceral and Cancer Surgery
[3] University Hospital Zurich,Department of Visceral and Transplantation Surgery
关键词
Rectal cancer; Neoadjuvant therapy; Response prediction; Prognosis; β-catenin; Her2/neu;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Strategies to target HER2/neu overexpression for cancer therapy
    Chen, JS
    Lan, K
    Hung, MC
    DRUG RESISTANCE UPDATES, 2003, 6 (03) : 129 - 136
  • [22] Comparison of serum HER2/neu with immunohistochemical HER2/neu expression for the prediction of biochemical progression in metastatic prostate cancer
    Tambo, Mitsuhiro
    Higashihara, Eiji
    Terado, Yuichi
    Nutahara, Kikuo
    Okegawa, Takatsugu
    INTERNATIONAL JOURNAL OF UROLOGY, 2009, 16 (04) : 369 - 374
  • [23] Serum HER2/neu levels in breast cancer patients with different level of tumor HER2/neu protein expression
    Kushlinsky, Nicolai
    Gershtein, Elena
    Shyroky, Vyacheslav
    Ermilova, Valeriya
    Tchemeris, Galina
    Letyagin, Victor
    TUMOR BIOLOGY, 2007, 28 : 95 - 95
  • [24] Influence of Neoadjuvant Chemotherapy on HER2/neu Status in Invasive Breast Cancer
    Li, Peifeng
    Liu, Tantan
    Wang, Yingmei
    Shao, Shuai
    Zhang, Weichen
    Lv, Yang
    Yi, Jun
    Wang, Zhe
    CLINICAL BREAST CANCER, 2013, 13 (01) : 53 - 60
  • [25] Down-regulation of HER2/neu expression induces apoptosis in human cancer cells that overexpress HER2/neu
    Roh, H
    Pippin, J
    Drebin, JA
    CANCER RESEARCH, 2000, 60 (03) : 560 - 565
  • [26] Human epidermal growth factor receptor-2 expression in locally advanced rectal cancer: Association with response to neoadjuvant therapy and prognosis
    Meng, Xiangjiao
    Wang, Renben
    Huang, Zhaoqin
    Zhang, Jianbo
    Feng, Rui
    Xu, Xiaoqing
    Zhu, Kunli
    Dou, Xue
    Chen, Dong
    Yu, Jinming
    CANCER SCIENCE, 2014, 105 (07) : 818 - 824
  • [27] The influence of hormone receptor status and HER1 and HER2 expression on the response to neoadjuvant therapy in breast cancer patients
    Bonigliere, L.
    Torrisi, R.
    Pruneri, G.
    Colleoni, M.
    Viale, G.
    LABORATORY INVESTIGATION, 2008, 88 : 24A - 24A
  • [28] The influence of hormone receptor status and HER1 and HER2 expression on the response to neoadjuvant therapy in breast cancer patients
    Bouiglieri, L.
    Torrisi, R.
    Pruneri, G.
    Colleoni, M.
    Viale, G.
    MODERN PATHOLOGY, 2008, 21 : 24A - 24A
  • [29] Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients
    Guarneri, V.
    Dieci, M. V.
    Barbieri, E.
    Piacentini, F.
    Omarini, C.
    Ficarra, G.
    Bettelli, S.
    Conte, P. F.
    ANNALS OF ONCOLOGY, 2013, 24 (12) : 2990 - 2994
  • [30] HER2/neu expression in locally advanced rectal cancer cUICC II/III and its correlation with long-term prognosis.
    Conradi, Lena-Christin
    Styczen, Hanna
    Sprenger, Thilo
    Becker, Heinz
    Ghadimi, Michael B.
    Beissbarth, Tim
    Middel, Peter
    Liersch, Torsten
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)